SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
-9.52%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$649M
AUM Growth
-$92.5M
(-12%)
Cap. Flow
-$6.29M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
84
New
16
Increased
18
Reduced
18
Closed
18
Top Buys
| 1 |
United Therapeutics
UTHR
|
$25.4M |
| 2 |
Illumina
ILMN
|
$21.8M |
| 3 |
OraSure Technologies
OSUR
|
$20.7M |
| 4 |
Hologic
HOLX
|
$17.3M |
| 5 |
Arcellx
ACLX
|
$13.9M |
Top Sells
| 1 |
Lantheus
LNTH
|
$87.7M |
| 2 |
AstraZeneca
AZN
|
$24.3M |
| 3 |
C4 Therapeutics
CCCC
|
$9.57M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$8.24M |
| 5 |
Smith & Nephew
SNN
|
$6.64M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.6% |
| 3 | Consumer Staples | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Steris
STE
$23.9B
| $9.98M | 1.29% |
41,260
-10,840
| -21% | -$2.62M |
|
|
27
Lantheus
LNTH
$3.66B
| $9.87M | 1.27% |
178,427
-1,586,200
| -90% | -$87.7M |
|
28
CVS Health
CVS
$93.3B
| $9.36M | 1.21% |
92,500
-45,500
| -33% | -$4.61M |
|
29
Supernus Pharmaceuticals
SUPN
$2.55B
| $8.11M | 1.05% |
+251,000
| New | +$8.11M |
|
30
10x Genomics
TXG
$1.68B
| $8.07M | 1.04% |
+106,139
| New | +$8.07M |
|
31
Fate Therapeutics
FATE
$114M
| $7.98M | 1.03% |
205,900
+198,100
| +2,540% | +$7.68M |
|
32
Vaxcyte
PCVX
$4.14B
| $7.93M | 1.02% |
328,350
+33,600
| +11% | +$811K |
|
33
Mirum Pharmaceuticals
MIRM
$3.74B
| $7.56M | 0.98% |
+343,500
| New | +$7.56M |
|
|
34
AstraZeneca
AZN
$253B
| $7.48M | 0.96% |
112,696
-365,900
| -76% | -$24.3M |
|
|
EIGR
35
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $6.5M | 0.84% |
+26,100
| New | +$6.5M |
|
36
Natera
NTRA
$23B
| $6.31M | 0.81% |
155,000
-72,599
| -32% | -$2.95M |
|
37
DexCom
DXCM
$31.6B
| $5.94M | 0.77% |
46,436
+15,400
| +50% | +$1.97M |
|
38
Xenon Pharmaceuticals
XENE
$2.97B
| $5.8M | 0.75% |
189,797
-189,200
| -50% | -$5.78M |
|
39
CVRx
CVRX
$200M
| $5.76M | 0.74% |
962,165
| – | – |
|
40
NeoGenomics
NEO
$1.04B
| $5.59M | 0.72% |
+460,000
| New | +$5.59M |
|
41
InMode
INMD
$911M
| $5.41M | 0.7% |
+146,500
| New | +$5.41M |
|
|
42
C4 Therapeutics
CCCC
$190M
| $4.05M | 0.52% |
166,736
-394,386
| -70% | -$9.57M |
|
43
The Beauty Health Co
SKIN
$254M
| $3.84M | 0.5% |
+227,612
| New | +$3.84M |
|
|
SIEN
44
DELISTED
Sientra, Inc.
SIEN
| $3.64M | 0.47% |
164,134
-25,054
| -13% | -$556K |
|
45
IO Biotech
IOBT
$118M
| $3.57M | 0.46% |
672,734
| – | – |
|
46
Xilio Therapeutics
XLO
$37M
| $3.38M | 0.44% |
477,495
| – | – |
|
|
ARYD
47
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $2.94M | 0.38% |
300,000
| – | – |
|
48
Y-mAbs Therapeutics
YMAB
$389M
| $2.84M | 0.37% |
238,982
-71,512
| -23% | -$850K |
|
49
Immunic
IMUX
$76.6M
| $2.71M | 0.35% |
240,000
+65,000
| +37% | +$735K |
|
50
Intuitive Surgical
ISRG
$162B
| $2.35M | 0.3% |
+7,800
| New | +$2.35M |
|